Skip to main content
Fig. 3 | Cancer Cell International

Fig. 3

From: The cholesterol esterification inhibitor avasimibe suppresses tumour proliferation and metastasis via the E2F-1 signalling pathway in prostate cancer

Fig. 3

Avasimibe suppressed PCa cell migration. a Wound healing assays of PCa cells after 48 h of avasimibe treatment; b quantitative results of the migration rate; c Transwell assays of PCa cells after 48 h of avasimibe treatment; d the quantitative results of the Transwell assays; e immunofluorescence staining of E-cadherin in PCa cells after avasimibe treatment; f protein levels of EMT-related proteins (β-catenin, Vimentin, N-cadherin, Snail, MMP9 and E-cadherin) in 48 h-avasimibe-treated PCa cells were determined by Western blotting. ***p < 0.001

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us